文献リスト

1) Gustafsson LE, Leone AM, Persson MG, et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophis Res Commun. 1991; 181: 852-7

2) Alving K, Weitzberg E, Lundberg J. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993; 6: 1368-70

3) Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997; 10: 1683-93

4) Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 1999; 160: 2104-17

5) Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343: 133-5

6) Persson MG, Zetterstrom O, Agrenius V, et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet. 1994; 343: 146-7

7) Ichinose M, Takahashi T, Sugiura H, et al. Baseline airway hperresponsiveness and its reversible component: role of airway inflammation and airway caliber. Eur Respir J. 2000; 15: 248-53

8) Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholie responsiveness in patients with mild asthma. Thorax. 1998; 53: 91-5

9) Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996; 153: 454-7

10) Kharitonov SA, Yates DH, Chung KF, et al. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J. 1996; 9: 64-72

11) Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000; 161: 64-72

12) van Asch CJ, Balemans WA, Rovers MM, et al. Atopic disease and exhaled nitric oxide in an unselected population of young adults. Ann Allergy Asthma Immunol. 2010; 100: 59-65

13) Scott M, Raza A, Karmaus W, et al. Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax. 2010; 65: 258-62

14) Nadif R, Matran R, Maccario J, et al. Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol. 2010; 105: 97-8

15) Verleden GM, Dupont LJ, Verpeut AC, et al. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics. Chest. 1999; 115: 59-64

16) Talor DR, Pijnenberg MW, Smith AD, et al. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006; 61: 817-27

17) Pedrosa M, Cancelliere M, Barranco P, et al. Usefulness of exhaled nitric oxide for diagnosis asthma. J Asthma. 2010; 47: 817-21

18) Kowal K, Bodzenta-Lukaszyk A, Zukowski S. Exhaled nitric oxide in evaluation of young adults with chronic cough. J Asthma. 2009; 46: 692-8

19) Schneider A, Tilemann L, Schermer T, et al. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement-results of a prospective diagnostic study. Respiratory Research. 2009; 10: 15

20) Sato S, Satio J, Sato Y, et al. Clinical usefulness of fraction exhaled nitric oxide for diagnosing prolonged cough. Respiratoy Medicine. 2008; 102: 1452-9

21) Fortuna AM, Feixas T, Gonzalez M, et al. Diagnostic utility of inflammatory biomarkers in asthma: Exhaled nitric oxide and induced sputum eosinophil count. Respiratory Medicine. 2007; 101: 2416-21

22) Bommarito L, Miglior E, Bugiani M, et al. Exhaled nitric oxide in a population sample of adults. Respiration. 2008; 75: 386-92

23) Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from random community survey of adults. Am J Repir Crit Care Med. 2007; 176: 238-42

24) Miedinger D, Chhajed PN, Tamm M, et al. Diagnostic tests for asthma in firefighters. Chest. 2007; 131: 1760-7

25) Arora R, Thornblade CE, Dauby PA, et al. Exhaled nitric oxide levels in military recruits with new on asthma. Allergy Asthma Proc. 2006; 27: 493-8

26) Heffler E, Guida G, Marsico P, et al. Exhaled nitric oxide as a diagnostic rest for asthma in rhinitic patients with asthmatic symptoms. Respiratory Medicine. 2006; 100: 1981-7

27) Berkman N, Avital A, Breuer R, et al. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation test. Thorax. 2005; 60: 383-8

28) Smith AD, Cowan JO, Filsell S, et al. Comparions between exhaled nitric oxide measurements and convention tests. Am J Respir Crit Care Med. 2004; 169: 473-8

29) Duppont LJ, Demedts MG, Vereden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest. 2003; 123: 751-6

30) Deykin A, Massaro AF, Drazen JM, et al. Exhaled nitric oxide as a diagnostic test for asthma. Am J Respir Crit Care Med. 2002; 165: 1597-601

31) Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med. 1999; 159: 1810-3

32) Ko FW, Leung TF, Hui DS, et al. Asthma Control Test correlates well with the treatment decisions made by asthma specialists. Respirology. 2009; 14: 559-66

33) Gelb AF, Flynn Taylor C, Shinar CM, et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006; 129: 1492-9

34) Menzies D, Jackson C, Mistry C, et al. Symptoms, spirometry, exhaled nitric oxide, and asthma exacerbations in clinical practice. Ann Allergy Asthma Immunol. 2008; 101: 248-55

35) Michils A, Louis R, Peché R, et al. Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J. 2009; 34: 1295-301

36) Leung TF, Ko FW, Sy HY, et al. Identifying uncontrolled asthma in young children: clinical scores or objective variables？ J Asthma. 2009; 46: 130-5

37) Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J. 2008; 31: 539-46

38) Robroeks CM, van de Kant KD, Jobsis Q, et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy. 2007; 37: 1303-11

39) Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001; 164: 738-43

40) Khalili B, Boggs PB, Shi R, et al. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2008; 101: 124-9

41) Petsky HL, Cates CL, Li AM, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2008; 006340

42) Schleich FN, Seidel L, Sele J, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≧3% in a cohort of unselected patients with asthma. Thorax. 2010; 65: 1039-44

43) Berry MA, Shaw DE, Green RH, et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy. 2005; 35: 1175-9

44) Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Therapeutic Advances in Respiratory Disease. 2007; 1: 5-23

45) Nording ML, Yang J, Hegedus CM, et al. Endogenous levels of five fatty acid metabolites in exhaled breath condensate to monitor asthma by high-performance liquid chromatography: Electrospray tandem mass spectrometry. Sensors J. 2010; 10: 123-30

46) Larstad M, Soderling AS, Caidahl K, et al. Selective quantification of free3-nitrotyrosine in exhaled breath condensate in asthma using gas chromatography/tandem mass spectrometry. Nitric Oxide. 2005; 13: 134-44

47) Esther CRjr, Boysen G, Olsen BM, et al. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2009; 296: L987-93

48) de Laurentiis G, Paris D, Melck D, et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J. 2008; 32: 1175-83

49) Bloemen K, Heuvel R, Van Den Govarts E, et al. A new approach to study exhaled proteins as potential biomarkers for asthma. Clin Exp Allergy. 2011; 41: 346-56

50) Carraro S, Rezzi S, Reniero F, et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2007; 175: 986-90

51) Effros RM, Hoagland KW, Bosbous M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med. 2002; 165: 663-9

52) Effros RM, Peterson B, Casaburi R, et al. Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects. J Appl Physiol. 2005; 99: 1286-92

53) Effros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensate. Am J Respir Crit Care Med. 2003; 168: 1500-5

54) Lazar Z, Cervenak L, Orosz M, et al. Adenosine triphosphate concentration of exhaled breath condensate in asthma. Chest. 2010; 138: 536-42

55) Davis CE, Bogan MJ, Sankaran S, et al. Analysis of volatile and non-volatile biomarkers in human breath using differential mobility spectrometry (DMS). IEEE Sens J. 2010; 10: 114-23

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp